TriSalus Life Sciences, Inc. TLSI Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$27.31M+30.4% | -$39.23M+0.9% | -$39.58M-27.0% | -$31.17M-14.5% | -$27.21M+9.4% | ||
| $589K-5.9% | $626K-9.7% | $693K-2.7% | $712K-3.9% | $741K-0.4% | ||
| $9.98M+9.3% | $9.13M+5.8% | $8.63M+30.9% | $6.59M+10.3% | $5.98M+9.8% | ||
| $1.11M+5.8% | $1.05M+11.0% | $945K+12.9% | $837K-1.2% | $847K+38.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $1.11M-18.7% | $1.36M-20.8% | ||
| -$384K+60.5% | -$971K-34.1% | -$724K-299% | $363K-70.9% | $1.25M-16.9% | ||
| $556K-72.5% | $2.02M+52.1% | $1.33M+160% | -$2.21M+19.8% | -$2.76M+41.2% | ||
| —— | —— | —— | —— | —— | ||
| $287K-33.1% | $429K-2.1% | $438K+36.0% | $322K-10.8% | $361K+36.7% | ||
| -$109K+18.7% | -$134K+8.8% | -$147K+22.2% | -$189K+24.1% | -$249K+10.4% | ||
| -$5.48M-300% | $2.74M+214% | -$2.4M-7.3% | -$2.24M+85.3% | -$15.23M-26.3% | ||
| -$19.99M-11.0% | -$18.01M+15.2% | -$21.24M+25.2% | -$28.37M+17.7% | -$34.48M+15.6% | ||
| —— | —— | —— | —— | $1.03M+199% | ||
| —— | —— | —— | —— | $40K— | ||
| —— | —— | —— | —— | -$993K-188% | ||
| —— | —— | —— | $30.57M+156% | $11.96M-20.8% | ||
| $19K-76.5% | $81K-16.5% | $97K-14.2% | $113K-15.0% | $133K+58.3% | ||
| —— | —— | —— | —— | $3.12M+20.0% | ||
| $63.46M+106% | $30.76M-8.1% | $33.48M-14.6% | $39.22M-11.9% | $44.5M+17.3% | ||
| —— | —— | —— | $10.01M+10.8% | $9.03M+378% | ||
| $4.13M+11.7% | $3.7M+46.2% | $2.53M-11.7% | $2.86M+16.2% | $2.46M+40.2% | ||
| —— | —— | —— | $30K+57.9% | $19K+5.6% | ||
| —— | —— | —— | —— | $179.25K-4.1% | ||
| $1.11M+5.8% | $1.05M+11.0% | $945K+12.9% | $837K-1.2% | $847K+38.4% | ||
| -$5.48M-300% | $2.74M+214% | -$2.4M-7.3% | -$2.24M+85.3% | -$15.23M-26.3% | ||
| $638K+116% | -$4.1M+12.5% | -$4.68M— | —— | —— | ||
| -$109K+18.7% | -$134K+8.8% | -$147K+22.2% | -$189K+24.1% | -$249K+10.4% | ||
| —— | —— | —— | —— | —— | ||
| $287K-33.1% | $429K-2.1% | $438K+36.0% | $322K-10.8% | $361K+36.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $40K— | ||
| $19K-76.5% | $81K-16.5% | $97K-14.2% | $113K-15.0% | $133K+58.3% | ||
| —— | —— | —— | —— | $3.12M+20.0% | ||
| —— | $404K-1.8% | $411.25K-1.7% | $418.5K-1.7% | $425.75K-1.7% | ||
| —— | —— | —— | —— | $87K— | ||
| —— | $0-100% | $2.98M-50.0% | $5.96M-33.3% | $8.94M-25.0% | ||
| —— | —— | —— | —— | $85K— | ||
| —— | —— | —— | —— | —— | ||
| -$109K+18.7% | -$134K+8.8% | -$147K+22.2% | -$189K+24.1% | -$249K+10.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $30K+57.9% | $19K+5.6% | ||
| -$20.3M-7.2% | -$18.93M+14.6% | -$22.16M+24.2% | -$29.25M+17.6% | -$35.51M+13.8% | ||
| -$20.3M-7.2% | -$18.93M+14.6% | -$22.16M+24.2% | -$29.25M+17.6% | -$35.51M+13.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TriSalus Life Sciences, Inc. generate?
- TriSalus Life Sciences, Inc. (TLSI) generated -$20.0M in operating cash flow over the trailing twelve months.
- What is TriSalus Life Sciences, Inc.'s free cash flow?
- After $1.2M of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$20.3M over the trailing twelve months, up 42.8% year over year.
- Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
